Here are the winning Lotto and Lotto Plus numbers from the Wednesday, 29 April, draw.Lotto: 9, 25, 26, 30, 33, 43 Bonus Ball: 23Lotto Plus 1: 20, 30, 34, 35, 42, 51 Bonus Ball: 48Lotto Plus 2: 37, 44, 47, 48, 50, 52 Bonus Ball: 43
Here are the winning Lotto and Lotto Plus numbers from the Wednesday, 29 April, draw.Lotto: 9, 25, 26, 30, 33, 43 Bonus Ball: 23Lotto Plus 1: 20, 30, 34, 35, 42, 51 Bonus Ball: 48Lotto Plus 2: 37, 44, 47, 48, 50, 52 Bonus Ball: 43Are you feeling lucky? See the payouts for the Lotto here, click here for Lotto Plus 1 and…
Here are the winning Lotto and Lotto Plus numbers from the Saturday, 25 April, draw.Lotto: 4, 24, 36, 39, 44, 48 Bonus Ball: 1Lotto Plus 1: 2, 10, 15, 34, 40, 43 Bonus Ball: 13Lotto Plus 2: 8, 10, 18, 31, 35, 36 Bonus Ball: 2
Here are the winning Lotto and Lotto Plus numbers from the Saturday, 25 April, draw.Lotto: 4, 24, 36, 39, 44, 48 Bonus Ball: 1Lotto Plus 1: 2, 10, 15, 34, 40, 43 Bonus Ball: 13Lotto Plus 2: 8, 10, 18, 31, 35, 36 Bonus Ball: 2Are you feeling lucky? See the payouts for the Lotto here, click here for Lotto Plus 1 and Lotto Plus…
The results of a highly anticipated study on an experimental coronavirus treatment for the sickest patients are expected any day.Physicians leading the clinical trial for the drug, called remdesivir, say the fast-moving pandemic has compelled them to work with haste, all without compromising the scientific rigor necessary to prove whether the drug really works.Full coverage…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f